From Promise to Practice: Enabling the Next Generation of Personalized Cancer Vaccines
9:00 am - Thursday 3rd December 2026
- Exploring key learnings from clinical and translational development of individualized cancer vaccines
- Leveraging targeted antigen delivery to professional APCs to generate potent, broad, and long-lasting immune responses
- Addressing manufacturing complexity, scalability, and cost to make personalized immunotherapies a sustainable commercial reality
